GeneDx Holdings WGS Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.6%+4.3pp | 69.7%+6.1pp | 69.6%+10.2pp | 67.2%+11.2pp | 65.3%+14.7pp | |
| Operating margin | -14.9%— | -3.1%— | —— | —— | —— | |
| Net margin | -17.6%— | -4.9%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | -30.4%— | -7.6%— | —— | —— | —— | |
| Return on invested capital | -28.3%— | -4.4%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.9×+0.1× | 0.9×+0.2× | 0.9×+0.2× | 0.8×+0.3× | 0.8×+0.3× | |
| Liquidity | ||||||
| Current ratio | 3.1×-0.2× | 2.5×-1.1× | 2.7×+0.3× | 2.9×+0.5× | 3.2×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×+0.2× | 0.4×-0.1× | 0.2×-0.1× | 0.2×-0.1× | 0.2×-0.1× | |
| Per Share | ||||||
| Book value per share | $8.66-5.3% | $10.76+18.0% | $10.15+34.5% | $9.31+27.8% | $9.14+15.0% | |
| Valuation | ||||||
| Market capitalization | $1.88B-24.3% | $3.76B+78.0% | $3.09B+171% | $2.59B+279% | $2.49B+945% | |
| Price / sales | 4.2×-3.3× | 8.8×+1.9× | 7.7×+3.4× | 7.2×+4.4× | 7.5×+6.5× | |
| Price / book | 7.4×-2.3× | 12.2×+3.6× | 10.6×+5.0× | 9.4×+5.8× | 9.7×+8.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GeneDx Holdings's profit margins?
- GeneDx Holdings (WGS) runs a 69.6% gross margin and a -14.9% operating margin, with a -17.6% net margin.
- Where do GeneDx Holdings's ratios come from?
- Every ratio is computed from GeneDx Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
